Lipella Pharmaceuticals Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lipella Pharmaceuticals Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $468.59K.
- Lipella Pharmaceuticals Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $80.67K, a 90.48% decline year-over-year.
- Lipella Pharmaceuticals Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $208.64K, a 0.00% change year-over-year.
- Lipella Pharmaceuticals Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $847.62K.
- Lipella Pharmaceuticals Inc. stock issued during period, value, new issues for fiscal 2023 was $388.40K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-09-30 | $468.59K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $80.67K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $208.64K 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $388.40K 10-K · filed 2024-02-27 | |
| 2023-06-30 | $847.62K 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $208.64K 10-Q · filed 2024-08-13 | |
| 2022-03-31 | $235.15K 10-Q · filed 2023-05-12 |